文献速递流行病学与生物统计临床试验与 GCP

婴儿床旁HIV诊断的临床效果:系统综述与Meta分析

The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
PubMed 文献 · Lancet · 2022-01-01

该系统综述与Meta分析纳入7项研究、15个国家共37377名HIV暴露婴儿,比较床旁核酸检测与实验室检测(标准照护)的临床效果。床旁检测组结果送达 caregivers 和启动抗逆转录病毒治疗的中位时间均显著短于标准照护组,HIV阳性婴儿60天内启动治疗的比例更高(90.3% vs 51.6%,OR 8.74)。证据确定性高。

要点

  • 床旁HIV检测组样本采集到结果送达 caregivers 中位0天,标准照护组35天。
  • 床旁检测组启动抗逆转录病毒治疗中位0天,标准照护组40天。
  • 床旁检测组90.3%的HIV阳性婴儿60天内启动治疗,标准照护组51.6%。

核心结论

  • 在HIV暴露婴儿中,同日床旁HIV检测与标准照护相比,可显著缩短结果送达时间和抗逆转录病毒治疗启动时间,并提高HIV阳性婴儿60天内启动治疗的比例。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、MEDLINE、Cochrane Central Register of Controlled Trials、Embase、Conference Proceedings Citation Index-Science和WHO Global Index Medicus,检索时间2014年1月1日至2020年8月31日。
  • 纳入7项研究,共37377名HIV暴露婴儿,来自15个国家;其中25170名(67%)接受床旁HIV检测,12207名(33%)接受标准照护检测。
  • 使用ROBINS-I框架评估偏倚风险,数据从已发表报告中提取。

主要发现

  • 床旁检测组样本采集到结果送达 caregivers 的中位时间为0天(95%CI 0-0),标准照护组为35天(95%CI 35-37),差异显著。
  • 床旁检测组HIV阳性婴儿从样本采集到启动抗逆转录病毒治疗的中位时间为0天(95%CI 0-1),标准照护组为40天(95%CI 36-44),差异显著。
  • 各研究结果等权加权后,床旁检测组90.3%(95%CI 76.7-96.5)的HIV阳性婴儿在样本采集后60天内启动抗逆转录病毒治疗,标准照护组为51.6%(95%CI 27.1-75.7),OR 8.74(95%CI 6.6-11.6),p<0.0001。
  • 主要结局(结果送达和治疗启动)的证据确定性评为高,无严重偏倚风险、不一致性、间接性或精确性问题。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Timely diagnosis and treatment of HIV is crucial in HIV-exposed infants to prevent the high rates of mortality seen during the first 2 years of life if HIV is untreated. However, challenges with sample transportation, testing, and result delivery to caregivers have led to long delays in treatment initiation. We aimed to compare the clinical effect of point-of-care HIV testing versus laboratory-based testing (standard of care) in HIV-exposed infants. METHODS: We did a systematic review and meta-analysis and searched PubMed, MEDLINE, Cochrane Central Register of Controlled Trials, Embase, Conference Proceedings Citation Index-Science, and WHO Global Index Medicus, from Jan 1, 2014, to Aug 31, 2020. Studies were included if they pertained to the use of point-of-care nucleic acid testing for infant HIV diagnosis, had a laboratory-based nucleic acid test as the comparator or standard of care against the index test (same-day point-of-care testing), evaluated clinical outcomes when point-of-care testing was used, and included HIV-exposed infants aged younger than 2 years. Studies were excluded if they did not use a laboratory-based comparator, a nucleic acid test that had been approved by a stringent regulatory authority, or diagnostic-accuracy or performance evaluations (eg, no clinical outcomes included). Reviews, non-research letters, commentaries, and editorials were also excluded. The risk of bias was evaluated using the ROBINS-I framework. Data were extracted from published reports. Data from all studies were analysed using frequency statistics to describe the overall populations evaluated and their results. Key outcomes were time to result delivery and antiretroviral therapy initiation, and proportion of HIV-positive infants initiated on antiretroviral therapy within 60 days after sample collection. FINDINGS: 164 studies were identified by the search and seven were included in the analysis, comprising 37 377 infants in total across 15 countries, including 25 170 (67%) who had point-of-care HIV testing and 12 207 (33%) who had standard-of-care testing. The certainty of evidence was high. Same-day point-of-care testing led to a significantly shorter time between sample collection and result delivery to caregivers compared with standard-of-care testing (median 0 days [95% CI 0-0] vs 35 days [35-37]). Time from sample collection to antiretroviral therapy initiation in infants found to be HIV-positive was significantly lower with point-of-care testing compared with standard of care (median 0 days [95% CI 0-1] vs 40 days [36-44]). When each study's result was weighted equally, 90·3% (95% CI 76·7-96·5) of HIV-positive infants diagnosed using point-of-care testing had started antiretroviral therapy within 60 days of sample collection, compared with only 51·6% (27·1-75·7) who had standard-of-care testing (odds ratio 8·74 [95% CI 6·6-11·6]; p<0·0001). INTERPRETATION: Overall, the certainty of the evidence in this analysis was rated as high for the primary outcomes related to result delivery and treatment initiation, with no serious risk of bias, inconsistency, indirectness, or imprecision. In HIV-exposed infants, same-day point-of-care HIV testing was associated with significantly improved time to result delivery, time to antiretroviral therapy initiation, and proportion of HIV-positive infants starting antiretroviral therapy within 60 days compared with standard of care. FUNDING: The Bill & Melinda Gates Foundation.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Luo R, Fong Y, Boeras D, et al. The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis. Lancet. 2022. PMID: 36116479. doi:10.1016/S0140-6736(22)01492-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。